Packaged Foods
Compare Stocks
5 / 10Stock Comparison
PAVS vs TAOP vs GFAI vs BCO vs CCSI
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Security & Protection Services
Security & Protection Services
Software - Infrastructure
PAVS vs TAOP vs GFAI vs BCO vs CCSI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Packaged Foods | Software - Infrastructure | Security & Protection Services | Security & Protection Services | Software - Infrastructure |
| Market Cap | $70K | $1M | $10M | $4.44B | $520M |
| Revenue (TTM) | $13M | $36M | $72M | $5.39B | $351M |
| Net Income (TTM) | $-27M | $-7M | $-24M | $180M | $88M |
| Gross Margin | 11.1% | 14.9% | 15.1% | 26.1% | 80.2% |
| Operating Margin | -10.3% | -15.7% | -27.4% | 10.7% | 42.9% |
| Forward P/E | 0.0x | — | — | 11.6x | 6.5x |
| Total Debt | $2M | $10M | $3M | $4.93B | $580M |
| Cash & Equiv. | $261K | $2M | $22M | $2.27B | $75M |
PAVS vs TAOP vs GFAI vs BCO vs CCSI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Paranovus Entertain… (PAVS) | 100 | 0.0 | -100.0% |
| Taoping Inc. (TAOP) | 100 | 0.2 | -99.8% |
| Guardforce AI Co., … (GFAI) | 100 | 0.3 | -99.7% |
| The Brink's Company (BCO) | 100 | 169.4 | +69.4% |
| Consensus Cloud Sol… (CCSI) | 100 | 95.4 | -4.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PAVS vs TAOP vs GFAI vs BCO vs CCSI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PAVS ranks third and is worth considering specifically for value.
- Lower P/E (0.0x vs 11.6x)
TAOP lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, GFAI doesn't own a clear edge in any measured category.
BCO carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 6 yrs, beta 1.10, yield 0.9%
- Rev growth 5.0%, EPS growth 29.5%, 3Y rev CAGR 5.1%
- 293.0% 10Y total return vs CCSI's -20.6%
- Lower volatility, beta 1.10, current ratio 1.51x
CCSI is the #2 pick in this set and the best alternative if quality and momentum is your priority.
- 25.1% margin vs PAVS's -211.2%
- +26.8% vs PAVS's -99.9%
- 13.2% ROA vs PAVS's -94.4%, ROIC 22.2% vs -27.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.0% revenue growth vs PAVS's -98.9% | |
| Value | Lower P/E (0.0x vs 11.6x) | |
| Quality / Margins | 25.1% margin vs PAVS's -211.2% | |
| Stability / Safety | Beta 1.10 vs GFAI's 2.31 | |
| Dividends | 0.9% yield; 6-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +26.8% vs PAVS's -99.9% | |
| Efficiency (ROA) | 13.2% ROA vs PAVS's -94.4%, ROIC 22.2% vs -27.1% |
PAVS vs TAOP vs GFAI vs BCO vs CCSI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
PAVS vs TAOP vs GFAI vs BCO vs CCSI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CCSI leads in 2 of 6 categories
BCO leads 2 • PAVS leads 0 • TAOP leads 0 • GFAI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CCSI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BCO is the larger business by revenue, generating $5.4B annually — 423.2x PAVS's $13M. CCSI is the more profitable business, keeping 25.1% of every revenue dollar as net income compared to PAVS's -2.1%. On growth, PAVS holds the edge at +180.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $13M | $36M | $72M | $5.4B | $351M |
| EBITDAEarnings before interest/tax | $531,773 | -$4M | -$12M | $797M | $164M |
| Net IncomeAfter-tax profit | -$27M | -$7M | -$24M | $180M | $88M |
| Free Cash FlowCash after capex | -$3M | -$3M | -$6M | $544M | $112M |
| Gross MarginGross profit ÷ Revenue | +11.1% | +14.9% | +15.1% | +26.1% | +80.2% |
| Operating MarginEBIT ÷ Revenue | -10.3% | -15.7% | -27.4% | +10.7% | +42.9% |
| Net MarginNet income ÷ Revenue | -2.1% | -19.6% | -32.9% | +3.3% | +25.1% |
| FCF MarginFCF ÷ Revenue | -23.5% | -8.1% | -8.8% | +10.1% | +32.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +180.3% | -2.6% | +3.6% | +10.3% | +1.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +76.9% | -51.7% | +38.9% | -35.3% | +21.5% |
Valuation Metrics
Evenly matched — PAVS and CCSI each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 6.5x trailing earnings, CCSI trades at a 72% valuation discount to BCO's 22.9x P/E. On an enterprise value basis, CCSI's 6.1x EV/EBITDA is more attractive than BCO's 8.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $70,061 | $1M | $10M | $4.4B | $520M |
| Enterprise ValueMkt cap + debt − cash | $2M | $9M | -$9M | $7.1B | $1.0B |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | -0.16x | -0.89x | 22.93x | 6.50x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.00x | — | — | 11.58x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.38x | — |
| EV / EBITDAEnterprise value multiple | — | — | — | 8.01x | 6.07x |
| Price / SalesMarket cap ÷ Revenue | 0.98x | 0.04x | 0.28x | 0.84x | 1.49x |
| Price / BookPrice ÷ Book value/share | 0.00x | 0.08x | 0.16x | 11.14x | 39.95x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 10.17x | 4.92x |
Profitability & Efficiency
CCSI leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
CCSI delivers a 52.9% return on equity — every $100 of shareholder capital generates $53 in annual profit, vs $-116 for PAVS. PAVS carries lower financial leverage with a 0.08x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCSI's 42.14x. On the Piotroski fundamental quality scale (0–9), GFAI scores 6/9 vs TAOP's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -116.2% | -46.7% | -69.7% | +45.6% | +52.9% |
| ROA (TTM)Return on assets | -94.4% | -21.7% | -50.2% | +2.5% | +13.2% |
| ROICReturn on invested capital | -27.1% | -27.1% | -41.6% | +14.3% | +22.2% |
| ROCEReturn on capital employed | -39.5% | -38.0% | -19.1% | +12.1% | +26.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.08x | 0.50x | 0.08x | 12.10x | 42.14x |
| Net DebtTotal debt minus cash | $2M | $8M | -$19M | $2.7B | $506M |
| Cash & Equiv.Liquid assets | $261,355 | $2M | $22M | $2.3B | $75M |
| Total DebtShort + long-term debt | $2M | $10M | $3M | $4.9B | $580M |
| Interest CoverageEBIT ÷ Interest expense | -11.83x | -52.63x | -167.24x | 3.90x | 5.95x |
Total Returns (Dividends Reinvested)
BCO leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BCO five years ago would be worth $13,932 today (with dividends reinvested), compared to $0 for PAVS. Over the past 12 months, CCSI leads with a +26.8% total return vs PAVS's -99.9%. The 3-year compound annual growth rate (CAGR) favors BCO at 20.6% vs PAVS's -93.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -94.8% | -6.8% | -26.3% | -7.3% | +30.2% |
| 1-Year ReturnPast 12 months | -99.9% | -78.3% | -53.2% | +19.4% | +26.8% |
| 3-Year ReturnCumulative with dividends | -100.0% | -99.3% | -93.8% | +75.3% | -21.8% |
| 5-Year ReturnCumulative with dividends | -100.0% | -99.9% | -99.5% | +39.3% | -20.6% |
| 10-Year ReturnCumulative with dividends | -100.0% | -99.9% | -99.5% | +293.0% | -20.6% |
| CAGR (3Y)Annualised 3-year return | -93.2% | -80.9% | -60.4% | +20.6% | -7.9% |
Risk & Volatility
Evenly matched — BCO and CCSI each lead in 1 of 2 comparable metrics.
Risk & Volatility
BCO is the less volatile stock with a 1.10 beta — it tends to amplify market swings less than GFAI's 2.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CCSI currently trades 89.3% from its 52-week high vs PAVS's 0.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.53x | 2.26x | 2.36x | 1.12x | 1.53x |
| 52-Week HighHighest price in past year | $1488.00 | $20.10 | $1.50 | $136.37 | $31.66 |
| 52-Week LowLowest price in past year | $1.02 | $1.18 | $0.38 | $80.10 | $19.24 |
| % of 52W HighCurrent price vs 52-week peak | +0.1% | +6.4% | +31.5% | +79.0% | +89.3% |
| RSI (14)Momentum oscillator 0–100 | 31.9 | 53.1 | 47.0 | 52.0 | 51.0 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 20K | 378K | 543K | 123K |
Analyst Outlook
BCO leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: BCO as "Buy", CCSI as "Buy". Consensus price targets imply 51.3% upside for BCO (target: $163) vs -11.6% for CCSI (target: $25). BCO is the only dividend payer here at 0.93% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | — | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | — | $163.00 | $25.00 |
| # AnalystsCovering analysts | — | — | — | 9 | 6 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.9% | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | — | 6 | 1 |
| Dividend / ShareAnnual DPS | — | — | — | $1.00 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +4.7% | +4.4% |
CCSI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BCO leads in 2 (Total Returns, Analyst Outlook). 2 tied.
PAVS vs TAOP vs GFAI vs BCO vs CCSI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PAVS or TAOP or GFAI or BCO or CCSI a better buy right now?
For growth investors, The Brink's Company (BCO) is the stronger pick with 5.
0% revenue growth year-over-year, versus -98. 9% for Paranovus Entertainment Technology Ltd. (PAVS). Consensus Cloud Solutions, Inc. (CCSI) offers the better valuation at 6. 5x trailing P/E, making it the more compelling value choice. Analysts rate The Brink's Company (BCO) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PAVS or TAOP or GFAI or BCO or CCSI?
On trailing P/E, Consensus Cloud Solutions, Inc.
(CCSI) is the cheapest at 6. 5x versus The Brink's Company at 22. 9x. On forward P/E, Paranovus Entertainment Technology Ltd. is actually cheaper at 0. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — PAVS or TAOP or GFAI or BCO or CCSI?
Over the past 5 years, The Brink's Company (BCO) delivered a total return of +39.
3%, compared to -100. 0% for Paranovus Entertainment Technology Ltd. (PAVS). Over 10 years, the gap is even starker: BCO returned +291. 2% versus PAVS's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PAVS or TAOP or GFAI or BCO or CCSI?
By beta (market sensitivity over 5 years), The Brink's Company (BCO) is the lower-risk stock at 1.
12β versus Guardforce AI Co. , Limited's 2. 36β — meaning GFAI is approximately 111% more volatile than BCO relative to the S&P 500. On balance sheet safety, Paranovus Entertainment Technology Ltd. (PAVS) carries a lower debt/equity ratio of 8% versus 42% for Consensus Cloud Solutions, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PAVS or TAOP or GFAI or BCO or CCSI?
By revenue growth (latest reported year), The Brink's Company (BCO) is pulling ahead at 5.
0% versus -98. 9% for Paranovus Entertainment Technology Ltd. (PAVS). On earnings-per-share growth, the picture is similar: Paranovus Entertainment Technology Ltd. grew EPS 96. 4% year-over-year, compared to -1870. 0% for Taoping Inc.. Over a 3-year CAGR, TAOP leads at 8. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PAVS or TAOP or GFAI or BCO or CCSI?
Consensus Cloud Solutions, Inc.
(CCSI) is the more profitable company, earning 24. 2% net margin versus -110. 3% for Paranovus Entertainment Technology Ltd. — meaning it keeps 24. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CCSI leads at 43. 0% versus -94. 8% for PAVS. At the gross margin level — before operating expenses — CCSI leads at 79. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PAVS or TAOP or GFAI or BCO or CCSI more undervalued right now?
On forward earnings alone, Paranovus Entertainment Technology Ltd.
(PAVS) trades at 0. 0x forward P/E versus 11. 6x for The Brink's Company — 11. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BCO: 51. 3% to $163. 00.
08Which pays a better dividend — PAVS or TAOP or GFAI or BCO or CCSI?
In this comparison, BCO (0.
9% yield) pays a dividend. PAVS, TAOP, GFAI, CCSI do not pay a meaningful dividend and should not be held primarily for income.
09Is PAVS or TAOP or GFAI or BCO or CCSI better for a retirement portfolio?
For long-horizon retirement investors, The Brink's Company (BCO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
12), 0. 9% yield, +291. 2% 10Y return). Taoping Inc. (TAOP) carries a higher beta of 2. 26 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BCO: +291. 2%, TAOP: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PAVS and TAOP and GFAI and BCO and CCSI?
These companies operate in different sectors (PAVS (Consumer Defensive) and TAOP (Technology) and GFAI (Industrials) and BCO (Industrials) and CCSI (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: PAVS is a small-cap quality compounder stock; TAOP is a small-cap quality compounder stock; GFAI is a small-cap quality compounder stock; BCO is a small-cap quality compounder stock; CCSI is a small-cap deep-value stock. BCO pays a dividend while PAVS, TAOP, GFAI, CCSI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.